Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The action of insulin in the central nervous system produces sympathetic nervous system activation (also called sympathoactivation), although the neuronal intracellular mechanisms that mediate this are unclear. We hypothesized that PI3K and MAPK, the major pathways involved in insulin receptor signaling, mediate sympathetic nerve responses to insulin. Intracerebroventricular administration of insulin in rat increased multifiber sympathetic nerve activity to the hindlimb, brown adipose tissue (BAT), adrenal gland, and kidney. Ex vivo biochemical studies of mediobasal hypothalamic tissue revealed that insulin stimulated the association of insulin receptor substrate-1 with the p85alpha subunit of PI3K and also tyrosine phosphorylation of p42 and p44 subunits of MAPK in the hypothalamus. In order to determine whether PI3K and/or MAPK were involved in insulin-mediated sympathoactivation, we tested the effect of specific inhibitors of PI3K (LY294002 and wortmannin) and MAPK (PD98059 and U0126) on regional sympathetic responses to insulin. Interestingly, regional sympathoactivation to insulin was differentially affected by blockade of PI3K and MAPK. Inhibition of PI3K specifically blocked insulin-induced sympathoactivation to the hindlimb, while inhibition of MAPK specifically blocked insulin-induced sympathoactivation to BAT. Sympathoactivation to corticotrophin-releasing factor, however, was not affected by inhibition of PI3K and MAPK. These data demonstrate that PI3K and MAPK are specific and regionally selective mediators of the action of insulin on the sympathetic nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 3×
“Insulin receptor signaling depends on the activation of diverse mechanisms (13, 14).”
BackgroundRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Self-citationPhosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Hypothalamic insulin signaling is required for inhibition of glucose production
Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L. (2002) · Nature Medicine · doi:10.1038/nm1202-798 · Cited by 904 · cited 1×
“Indeed, the action of insulin in the hypothalamus has been reported to decrease glucose production (24) and plasma glucose concentrations (25).”
BackgroundDecreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats
Obici, S., Feng, Z., Karkanias, G., Baskin, D. G., & Rossetti, L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-861 · Cited by 719 · cited 1×
“In contrast, downregulation of insulin receptors in the hypothalamus using insulin receptor antisense oligodeoxynucleotide (20) as well as neuron-specific deletion of this receptor throughout the central nervous system (21) increases fat mass.”
BackgroundInhibition of hypothalamic neuropeptide Y gene expression by insulin.
Schwartz, M. W., Sipols, A. J., Marks, J. L., Sanacora, G., White, J. D., Scheurink, A., Kahn, S. E., Baskin, D. G., Woods, S. C., & Figlewicz, D. P. (1992) · Endocrinology · doi:10.1210/endo.130.6.1597158 · Cited by 555
Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats
Spanswick, D., Smith, M. A., Mirshamsi, S., Routh, V. H., & Ashford, M. L. J. (2000) · Nature Neuroscience · doi:10.1038/77660 · Cited by 495 · cited 1×
“(32) have shown that blockade of PI3K, but not MAPK, abolishes the neuronal hyperpolarization induced by insulin.”
BackgroundInsulin Activation of Phosphatidylinositol 3-Kinase in the Hypothalamic Arcuate Nucleus
Niswender, K. D., Morrison, C. D., Clegg, D. J., Olson, R., Baskin, D. G., Myers, M. G., Seeley, R. J., & Schwartz, M. W. (2003) · Diabetes · doi:10.2337/diabetes.52.2.227 · Cited by 476
The Catabolic Action of Insulin in the Brain Is Mediated by Melanocortins
Benoit, S. C., Air, E. L., Coolen, L. M., Strauss, R., Jackman, A., Clegg, D. J., Seeley, R. J., & Woods, S. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09048.2002 · Cited by 417
Scherrer, U., & Sartori, C. (1997) · Circulation · doi:10.1161/01.cir.96.11.4104 · Cited by 371
Berne, C., Fagius, J., Pollare, T., & Hjemdahl, P. (1992) · Diabetologia · doi:10.1007/bf00399935 · Cited by 293
Insulin and Leptin as Adiposity Signals
Benoit, S. C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.267 · Cited by 266
Lembo, G., Napoli, R., Capaldo, B., Rendina, V, Iaccarino, G., Volpe, M., Trimarco, B., & Saccà, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115842 · Cited by 252
Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin
Rahmouni, K., Haynes, W. G., Morgan, D. A., & Mark, A. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-14-05998.2003 · Cited by 185
Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats
Carvalheira, J. B. C., Ribeiro, E. B., Ara�jo, E. P., Guimar�es, R. B., Telles, M. M., Torsoni, M., Gontijo, J. A. R., Velloso, L. A., & Saad, M. J. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1246-x · Cited by 176 · cited 1×
“Hypothalamic PI3K also appears to be a key component in the effects of insulin on food intake and body weight, as blockade of this enzyme prevents the anorexic and weight-reducing effects of insulin (33, 34).”
Background
Research works printed but not linked: 27
- 10.1172/JCI110572 · DOI · Paper page
- Tomiyama, 1992, Hypertension., 20, 596, 10.1161/01.HYP.20.5.596 · DOI · Paper page
- 10.2337/diabetes.44.6.641 · doi:10.2337/diabetes.44.6.641
- Morgan, 1993, Am. J. Physiol., 264, R423
- Muntzel, 1994, Am. J. Physiol., 267, R1350
- Muntzel, 1994, Hypertension., 23, 1059, 10.1161/01.HYP.23.6.1059 · DOI · Paper page
- 10.1038/272827a0 · DOI · Paper page
- Werther, 1987, Endocrinology., 121, 1562, 10.1210/endo-121-4-1562 · DOI · Paper page
- 10.1016/S0303-7207(01)00455-5 · DOI · Paper page
- 10.1002/1521-1878(200103)23:3<215::AID-BIES1031>3.0.CO;2-S · DOI
- Correia, 2001, Hypertension., 38, 384, 10.1161/01.HYP.38.3.384 · DOI · Paper page
- 10.1038/nn861 · DOI
- 10.1016/0006-8993(91)90342-S · DOI
- 10.1016/0014-5793(90)80941-B · DOI
- 10.1038/nm798 · DOI
- Szabo, 1983, Adv. Metab. Disord., 10, 385, 10.1016/B978-0-12-027310-2.50020-7 · DOI
- 10.2337/diabetes.24.4.328 · doi:10.2337/diabetes.24.4.328
- Edwards, 1989, J. Appl. Physiol., 67, 2335, 10.1152/jappl.1989.67.6.2335 · DOI
- Meehan, 1994, Hypertension., 23, 1012, 10.1161/01.HYP.23.6.1012 · DOI
- Rocchini, 1989, Hypertension., 14, 367, 10.1161/01.HYP.14.4.367 · DOI · Paper page
- Porter, 1994, Am. J. Physiol., 266, R1463
- 10.1097/00004872-200103001-00001 · DOI · Paper page
- 10.1210/en.130.6.3608 · doi:10.1210/en.130.6.3608 · Paper page
- 10.1042/0264-6021:3510095 · doi:10.1042/0264-6021:3510095 · Paper page
- 10.1074/jbc.270.46.27489 · DOI · Paper page
- 10.1074/jbc.273.29.18623 · DOI · Paper page
- Morgan, 1988, FASEB J., 2, A1690
Cited by
Obesity and leptin resistance: distinguishing cause from effect
Myers, M. G., Leibel, R. L., Seeley, R. J., & Schwartz, M. W. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.002 · Cited by 901
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Obesity-Associated Hypertension: New Insights Into Mechanisms
Rahmouni, K., Correia, M. L. G., Haynes, W. G., & Mark, A. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 784
Self-citationHypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
López, M., Varela, L., Vázquez, M. J., Rodríguez-Cuenca, S., González, C. R., Velagapudi, V. R., Morgan, D. A., Schoenmakers, E., Agassandian, K., Lage, R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2207 · Cited by 681
Self-citationBrain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H., & Häring, H.-U. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 622
Metadata
- Authors
- Rahmouni, K., Morgan, D. A., Morgan, G. M., Liu, X., Sigmund, C. D., Mark, A. L., & Haynes, W. G.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-09-01
- Volume
- 114
- Issue
- 5
- Pages
- 652-658
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2136824109
- Cited by
- 188
- References
- 17
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.